CAPRICOR THERAPEUTICS, INC. Research and Development Expense
CAPRICOR THERAPEUTICS, INC. (CAPR) reported Research and Development Expense of $28.87 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-14
- CAPRICOR THERAPEUTICS, INC. research and development expense for the quarter ending 2026-06-30 was $28.87M, a 30.93% increase year-over-year.
- CAPRICOR THERAPEUTICS, INC. research and development expense for the quarter ending 2026-03-31 was $27.38M, a 44.73% increase year-over-year.
- CAPRICOR THERAPEUTICS, INC. research and development expense for the quarter ending 2025-12-31 was $23.13M, a 58.93% increase year-over-year.
- CAPRICOR THERAPEUTICS, INC. research and development expense for the quarter ending 2025-09-30 was $20.36M, a 72.42% increase year-over-year.
- CAPRICOR THERAPEUTICS, INC. research and development expense for fiscal 2025 was $84.45M, a 69.02% increase from fiscal 2024.
- CAPRICOR THERAPEUTICS, INC. research and development expense for fiscal 2024 was $49.97M, a 37.10% increase from fiscal 2023.
- CAPRICOR THERAPEUTICS, INC. research and development expense for fiscal 2023 was $36.45M, a 67.06% increase from fiscal 2022.
- CAPRICOR THERAPEUTICS, INC. research and development expense for fiscal 2022 was $21.82M, a 60.76% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed | Research and Development Expense 71 month | Research and Development Expense 74 month | Research and Development Expense 77 month | Research and Development Expense 80 month | Research and Development Expense 83 month | Research and Development Expense 86 month | Research and Development Expense 89 month | Research and Development Expense 92 month | Research and Development Expense 95 month | Research and Development Expense 98 month | Research and Development Expense 102 month | Research and Development Expense 105 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $28.87M 10-Q · filed 2026-08-14 | $56.24M 10-Q · filed 2026-08-14 | $79.38M derived: sum of 3 quarters · filed 2026-08-14 | $99.73M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||||||||||
| 2026-03-31 | $27.38M 10-Q · filed 2026-05-13 | $50.51M derived: sum of 2 quarters · filed 2026-05-13 | $70.87M derived: sum of 3 quarters · filed 2026-05-13 | $92.92M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||||||||||
| 2025-12-31 | $23.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $43.49M derived: sum of 2 quarters · filed 2026-03-17 | $65.54M derived: sum of 3 quarters · filed 2026-08-14 | $84.45M 10-K · filed 2026-03-17 | ||||||||||||||||
| 2025-09-30 | $20.36M 10-Q · filed 2025-11-10 | $42.41M derived: sum of 2 quarters · filed 2026-08-14 | $61.32M 10-Q · filed 2025-11-10 | $75.88M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||||||||||
| 2025-06-30 | $22.05M 10-Q · filed 2026-08-14 | $40.96M 10-Q · filed 2026-08-14 | $55.52M derived: sum of 3 quarters · filed 2026-08-14 | $67.33M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||||||||||
| 2025-03-31 | $18.92M 10-Q · filed 2026-05-13 | $33.47M derived: sum of 2 quarters · filed 2026-05-13 | $45.28M derived: sum of 3 quarters · filed 2026-05-13 | $57.78M derived: sum of 4 quarters · filed 2026-05-13 | ||||||||||||||||
| 2024-12-31 | $14.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $26.36M derived: sum of 2 quarters · filed 2026-03-17 | $38.87M derived: sum of 3 quarters · filed 2026-03-17 | $49.97M 10-K · filed 2026-03-17 | ||||||||||||||||
| 2024-09-30 | $11.81M 10-Q · filed 2025-11-10 | $24.31M derived: sum of 2 quarters · filed 2025-11-10 | $35.41M 10-Q · filed 2025-11-10 | $45.35M derived: sum of 4 quarters · filed 2025-11-10 | ||||||||||||||||
| 2024-06-30 | $12.50M 10-Q · filed 2025-08-11 | $23.61M 10-Q · filed 2025-08-11 | $33.55M derived: sum of 3 quarters · filed 2025-08-11 | $43.57M derived: sum of 4 quarters · filed 2025-08-11 | ||||||||||||||||
| 2024-03-31 | $11.10M 10-Q · filed 2025-05-14 | $21.04M derived: sum of 2 quarters · filed 2025-05-14 | $31.07M derived: sum of 3 quarters · filed 2025-05-14 | $39.89M derived: sum of 4 quarters · filed 2025-05-14 | ||||||||||||||||
| 2023-12-31 | $9.94M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $19.97M derived: sum of 2 quarters · filed 2025-03-26 | $28.79M derived: sum of 3 quarters · filed 2025-03-26 | $36.45M 10-K · filed 2025-03-26 | ||||||||||||||||
| 2023-09-30 | $10.03M 10-Q · filed 2024-11-14 | $18.85M derived: sum of 2 quarters · filed 2024-11-14 | $26.51M 10-Q · filed 2024-11-14 | $32.74M derived: sum of 4 quarters · filed 2024-11-14 | ||||||||||||||||
| 2023-06-30 | $8.82M 10-Q · filed 2024-08-08 | $16.48M 10-Q · filed 2024-08-08 | $22.71M derived: sum of 3 quarters · filed 2024-08-08 | $28.22M derived: sum of 4 quarters · filed 2024-08-08 | ||||||||||||||||
| 2023-03-31 | $7.66M 10-Q · filed 2024-05-14 | $13.89M derived: sum of 2 quarters · filed 2024-05-14 | $19.40M derived: sum of 3 quarters · filed 2024-05-14 | $24.36M derived: sum of 4 quarters · filed 2024-05-14 | ||||||||||||||||
| 2022-12-31 | $6.23M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $11.74M derived: sum of 2 quarters · filed 2024-03-11 | $16.70M derived: sum of 3 quarters · filed 2024-03-11 | $21.82M 10-K · filed 2024-03-11 | ||||||||||||||||
| 2022-09-30 | $5.50M 10-Q · filed 2023-11-14 | $10.47M derived: sum of 2 quarters · filed 2023-11-14 | $15.59M 10-Q · filed 2023-11-14 | $19.85M derived: sum of 4 quarters · filed 2023-11-14 | ||||||||||||||||
| 2022-06-30 | $4.97M 10-Q · filed 2023-08-08 | $10.08M 10-Q · filed 2023-08-08 | $14.34M derived: sum of 3 quarters · filed 2023-08-08 | $16.86M derived: sum of 4 quarters · filed 2023-08-08 | ||||||||||||||||
| 2022-03-31 | $5.12M 10-Q · filed 2023-05-12 | $9.38M derived: sum of 2 quarters · filed 2023-05-12 | $11.89M derived: sum of 3 quarters · filed 2023-05-12 | $15.39M derived: sum of 4 quarters · filed 2023-05-12 | ||||||||||||||||
| 2021-12-31 | $4.26M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-17 | $6.78M derived: sum of 2 quarters · filed 2023-03-17 | $10.27M derived: sum of 3 quarters · filed 2023-03-17 | $13.57M 10-K · filed 2023-03-17 | ||||||||||||||||
| 2021-09-30 | $2.51M 10-Q · filed 2022-11-10 | $6.01M derived: sum of 2 quarters · filed 2022-11-10 | $9.31M 10-Q · filed 2022-11-10 | $12.05M derived: sum of 4 quarters · filed 2022-11-10 | ||||||||||||||||
| 2021-06-30 | $3.50M 10-Q · filed 2022-08-12 | $6.79M 10-Q · filed 2022-08-12 | $9.54M derived: sum of 3 quarters · filed 2022-08-12 | $12.17M derived: sum of 4 quarters · filed 2022-08-12 | ||||||||||||||||
| 2021-03-31 | $3.30M 10-Q · filed 2022-05-11 | $6.04M derived: sum of 2 quarters · filed 2022-05-11 | $8.67M derived: sum of 3 quarters · filed 2022-05-11 | $10.60M derived: sum of 4 quarters · filed 2022-05-11 | ||||||||||||||||
| 2020-12-31 | $2.75M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $5.37M derived: sum of 2 quarters · filed 2022-03-11 | $7.30M derived: sum of 3 quarters · filed 2022-03-11 | $8.46M 10-K · filed 2022-03-11 | ||||||||||||||||
| 2020-09-30 | $2.63M 10-Q · filed 2021-11-12 | $4.56M derived: sum of 2 quarters · filed 2021-11-12 | $5.71M 10-Q · filed 2021-11-12 | $6.54M derived: sum of 4 quarters · filed 2021-11-12 | ||||||||||||||||
| 2020-06-30 | $1.93M 10-Q · filed 2021-08-13 | $3.08M 10-Q · filed 2021-08-13 | $3.91M derived: sum of 3 quarters · filed 2021-08-13 | $4.77M derived: sum of 4 quarters · filed 2021-08-13 | ||||||||||||||||
| 2020-03-31 | $1.16M 10-Q · filed 2021-05-14 | $1.98M derived: sum of 2 quarters · filed 2021-05-14 | $2.84M derived: sum of 3 quarters · filed 2021-05-14 | $4.49M derived: sum of 4 quarters · filed 2021-05-14 | ||||||||||||||||
| 2019-12-31 | $828.75K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $1.69M derived: sum of 2 quarters · filed 2021-03-15 | $3.33M derived: sum of 3 quarters · filed 2021-03-15 | $5.14M 10-K · filed 2021-03-15 | ||||||||||||||||
| 2019-09-30 | $857.76K 10-Q · filed 2020-11-13 | $2.50M derived: sum of 2 quarters · filed 2020-11-13 | $4.31M 10-Q · filed 2020-11-13 | $7.16M derived: sum of 4 quarters · filed 2020-11-13 | ||||||||||||||||
| 2019-06-30 | $1.64M 10-Q · filed 2020-08-10 | $3.46M 10-Q · filed 2020-08-10 | $6.30M derived: sum of 3 quarters · filed 2020-08-10 | $9.44M derived: sum of 4 quarters · filed 2020-08-10 | ||||||||||||||||
| 2019-03-31 | $1.81M 10-Q · filed 2020-05-15 | $4.66M derived: sum of 2 quarters · filed 2020-05-15 | $7.79M derived: sum of 3 quarters · filed 2020-05-15 | $11.18M derived: sum of 4 quarters · filed 2020-05-15 | ||||||||||||||||
| 2018-12-31 | $2.85M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $5.98M derived: sum of 2 quarters · filed 2020-03-27 | $9.37M derived: sum of 3 quarters · filed 2020-03-27 | $12.07M 10-K · filed 2020-03-27 | ||||||||||||||||
| 2018-09-30 | $3.13M 10-Q · filed 2019-11-08 | $6.52M derived: sum of 2 quarters · filed 2019-11-08 | $9.22M 10-Q · filed 2019-11-08 | $11.74M derived: sum of 4 quarters · filed 2019-11-08 | ||||||||||||||||
| 2018-06-30 | $3.39M 10-Q · filed 2019-08-08 | $6.09M 10-Q · filed 2019-08-08 | $8.60M derived: sum of 3 quarters · filed 2019-08-08 | $10.47M derived: sum of 4 quarters · filed 2019-08-08 | ||||||||||||||||
| 2018-03-31 | $2.70M 10-Q · filed 2019-05-14 | $5.21M derived: sum of 2 quarters · filed 2019-05-14 | $7.08M derived: sum of 3 quarters · filed 2019-05-14 | $10.21M derived: sum of 4 quarters · filed 2019-05-14 | ||||||||||||||||
| 2017-12-31 | $2.52M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $4.38M derived: sum of 2 quarters · filed 2019-03-29 | $7.51M derived: sum of 3 quarters · filed 2019-03-29 | $10.77M 10-K · filed 2019-03-29 | ||||||||||||||||
| 2017-09-30 | $1.86M 10-Q · filed 2018-11-14 | $4.99M derived: sum of 2 quarters · filed 2018-11-14 | $8.25M 10-Q · filed 2018-11-14 | $10.91M derived: sum of 4 quarters · filed 2018-11-14 | ||||||||||||||||
| 2017-06-30 | $3.13M 10-Q · filed 2018-08-13 | $6.39M 10-Q · filed 2018-08-13 | $9.05M derived: sum of 3 quarters · filed 2018-08-13 | $13.78M derived: sum of 4 quarters · filed 2018-08-13 | ||||||||||||||||
| 2017-03-31 | $3.26M 10-Q · filed 2018-05-14 | $5.92M derived: sum of 2 quarters · filed 2018-05-14 | $10.65M derived: sum of 3 quarters · filed 2018-05-14 | $14.96M derived: sum of 4 quarters · filed 2018-05-14 | ||||||||||||||||
| 2016-12-31 | $2.67M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | $7.39M derived: sum of 2 quarters · filed 2018-03-22 | $11.70M derived: sum of 3 quarters · filed 2018-03-22 | $16.04M 10-K · filed 2018-03-22 | ||||||||||||||||
| 2016-09-30 | $4.73M 10-Q · filed 2017-11-14 | $9.04M derived: sum of 2 quarters · filed 2017-11-14 | $13.38M 10-Q · filed 2017-11-14 | $16.71M derived: sum of 4 quarters · filed 2017-11-14 | ||||||||||||||||
| 2016-06-30 | $4.31M 10-Q · filed 2017-08-14 | $8.65M 10-Q · filed 2017-08-14 | $11.98M derived: sum of 3 quarters · filed 2017-08-14 | $15.17M derived: sum of 4 quarters · filed 2017-08-14 | ||||||||||||||||
| 2016-03-31 | $4.34M 10-Q · filed 2017-05-15 | $7.67M derived: sum of 2 quarters · filed 2017-05-15 | $10.86M derived: sum of 3 quarters · filed 2017-05-15 | $14.29M derived: sum of 4 quarters · filed 2017-05-15 | ||||||||||||||||
| 2015-12-31 | $3.33M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $6.52M derived: sum of 2 quarters · filed 2017-03-16 | $9.95M derived: sum of 3 quarters · filed 2017-03-16 | $13.76M 10-K · filed 2017-03-16 | ||||||||||||||||
| 2015-09-30 | $3.19M 10-Q · filed 2016-11-14 | $6.62M derived: sum of 2 quarters · filed 2016-08-15 | $10.43M 10-Q · filed 2016-11-14 | $13.01M derived: sum of 4 quarters · filed 2016-08-15 | ||||||||||||||||
| 2015-06-30 | $3.43M 10-Q · filed 2016-08-15 | $7.23M 10-Q · filed 2016-08-15 | $9.82M derived: sum of 3 quarters · filed 2016-08-15 | $11.78M derived: sum of 4 quarters · filed 2016-08-15 | ||||||||||||||||
| 2015-03-31 | $3.81M 10-Q · filed 2016-05-13 | $6.39M derived: sum of 2 quarters · filed 2016-05-13 | $8.36M derived: sum of 3 quarters · filed 2016-05-13 | $10.21M derived: sum of 4 quarters · filed 2016-05-13 | ||||||||||||||||
| 2014-12-31 | $2.58M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $4.55M derived: sum of 2 quarters · filed 2016-03-30 | $6.41M derived: sum of 3 quarters · filed 2016-03-30 | $7.79M 10-K · filed 2016-03-30 | ||||||||||||||||
| 2014-09-30 | $1.97M 10-Q · filed 2015-11-13 | $3.82M derived: sum of 2 quarters · filed 2015-11-13 | $5.20M 10-Q · filed 2015-11-13 | $6.88M derived: sum of 4 quarters · filed 2015-11-13 | ||||||||||||||||
| 2014-06-30 | $1.86M 10-Q · filed 2015-08-14 | $3.24M 10-Q · filed 2015-08-14 | $4.91M derived: sum of 3 quarters · filed 2015-08-14 | $5.93M derived: sum of 4 quarters · filed 2015-08-14 | ||||||||||||||||
| 2014-03-31 | $1.37M 10-Q · filed 2015-05-13 | $3.06M derived: sum of 2 quarters · filed 2015-05-13 | $4.07M derived: sum of 3 quarters · filed 2015-05-13 | $5.38M derived: sum of 4 quarters · filed 2015-05-13 | $12.87M 10-Q · filed 2014-05-15 | |||||||||||||||
| 2013-12-31 | $1.68M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $2.69M derived: sum of 2 quarters · filed 2015-03-16 | $4.01M derived: sum of 3 quarters · filed 2015-03-16 | $5.20M 10-K · filed 2015-03-16 | $11.50M 10-K · filed 2014-03-31 | |||||||||||||||
| 2013-09-30 | $1.01M 10-Q · filed 2014-11-14 | $30.88K 10-Q · filed 2013-11-14 | $2.32M derived: sum of 2 quarters · filed 2014-11-14 | $3.51M 10-Q · filed 2014-11-14 | $130.00K 10-Q · filed 2013-11-14 | $5.17M derived: sum of 4 quarters · filed 2014-11-14 | $31.15M 10-Q · filed 2013-11-14 | |||||||||||||
| 2013-06-30 | $1.31M 10-Q · filed 2014-08-14 | $36.51K 10-Q · filed 2013-08-14 | $2.50M 10-Q · filed 2014-08-14 | $99.12K 10-Q · filed 2013-08-14 | $4.16M derived: sum of 3 quarters · filed 2014-08-14 | $4.34M derived: sum of 4 quarters · filed 2014-08-14 | $31.12M 10-Q · filed 2013-08-14 | |||||||||||||
| 2013-03-31 | $1.19M 10-Q · filed 2014-05-15 | $62.60K 10-Q · filed 2013-06-21 | $2.85M derived: sum of 2 quarters · filed 2014-05-15 | $3.03M derived: sum of 3 quarters · filed 2014-05-15 | $3.36M derived: sum of 4 quarters · filed 2014-05-15 | $31.08M 10-Q · filed 2013-06-21 | ||||||||||||||
| 2012-12-31 | $1.66M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $1.84M derived: sum of 2 quarters · filed 2014-03-31 | $2.17M derived: sum of 3 quarters · filed 2014-03-31 | $2.63M 10-K · filed 2014-03-31 | $1.02M 10-K · filed 2013-06-21 | $31.02M 10-K · filed 2013-06-21 | ||||||||||||||
| 2012-09-30 | $179.14K 10-Q · filed 2013-11-14 | $511.59K derived: sum of 2 quarters · filed 2013-11-14 | $976.95K 10-Q · filed 2013-11-14 | $2.32M derived: sum of 4 quarters · filed 2013-11-14 | $30.97M 10-Q · filed 2013-06-21 | |||||||||||||||
| 2012-06-30 | $332.45K 10-Q/A · filed 2012-09-10 | $797.80K 10-Q · filed 2013-08-14 | $2.14M derived: sum of 3 quarters · filed 2013-08-14 | $3.61M derived: sum of 4 quarters · filed 2013-08-14 | $30.79M 10-Q/A · filed 2012-09-10 | |||||||||||||||
| 2012-03-31 | $465.35K 10-Q · filed 2013-06-21 | $1.81M derived: sum of 2 quarters · filed 2013-06-21 | $3.28M derived: sum of 3 quarters · filed 2013-06-21 | $3.98M derived: sum of 4 quarters · filed 2013-06-21 | $30.46M 10-Q · filed 2012-05-15 | |||||||||||||||
| 2011-12-31 | $1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-21 | $2.81M derived: sum of 2 quarters · filed 2013-06-21 | $3.51M derived: sum of 3 quarters · filed 2013-06-21 | $4.14M 10-K · filed 2013-06-21 | $30.00M 10-K · filed 2012-04-02 | |||||||||||||||
| 2011-09-30 | $1.47M 10-Q · filed 2013-06-21 | $2.17M derived: sum of 2 quarters · filed 2013-06-21 | $2.80M 10-Q · filed 2013-06-21 | $3.36M derived: sum of 4 quarters · filed 2013-06-21 | $28.65M 10-Q · filed 2011-11-14 | |||||||||||||||
| 2011-06-30 | $702.93K 10-Q/A · filed 2012-09-10 | $1.33M 10-Q/A · filed 2012-09-10 | $1.89M derived: sum of 3 quarters · filed 2012-09-10 | $3.04M derived: sum of 4 quarters · filed 2012-09-10 | $27.18M 10-Q · filed 2011-08-15 | |||||||||||||||
| 2011-03-31 | $622.33K 10-Q · filed 2012-05-15 | $1.19M derived: sum of 2 quarters · filed 2012-05-15 | $2.33M derived: sum of 3 quarters · filed 2012-05-15 | $3.39M derived: sum of 4 quarters · filed 2012-05-15 | ||||||||||||||||
| 2010-12-31 | $563.06K derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-02 | $1.71M derived: sum of 2 quarters · filed 2012-04-02 | $2.77M derived: sum of 3 quarters · filed 2012-04-02 | $4.08M 10-K · filed 2012-04-02 | ||||||||||||||||
| 2010-09-30 | $1.15M 10-Q · filed 2011-11-14 | $2.20M derived: sum of 2 quarters · filed 2011-11-14 | $3.52M 10-Q · filed 2011-11-14 | |||||||||||||||||
| 2010-06-30 | $1.06M 10-Q · filed 2011-08-15 | $2.37M 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |